Robotic mitral valve repair with force feedback tools
Part of Heart & circulation clinical trials.
This trial tests a new robotic tool that gives surgeons a sense of touch during mitral valve repair. If you have a severe leak in your mitral valve and are a good candidate for minimally invasive surgery, this study may offer a way to fix it using the da Vinci robot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 22 years old or older.
- You have a severe leak in your mitral valve (mitral regurgitation) that can be fixed with surgery.
- You have not had any previous heart surgery or robotic chest surgery on the same side.
- Your overall risk of complications from surgery is low (under 4% as calculated by your doctor).
- You are willing to have the surgery done through small incisions using a robot, instead of a large cut.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter-based device to fix a leaky mitral valve without open-heart surgery. It is for people whose severe mitral regurgitation puts them at high risk for traditional surgery.
This trial studies a minimally invasive mitral valve repair/replacement approach for people with severe mitral regurgitation (leaky mitral valve) who are not good candidates for standard surgery or catheter options. It may help improve symptoms by treating the leaky valve when other treatments aren’t suitable.
This trial studies whether a new catheter-based system can replace a badly leaking mitral valve in people who have symptoms. It may help if you can’t safely get current approved valve treatments or standard surgery.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This trial tests a new device called MRace that may fix a leaky mitral valve without open-heart surgery. It's for people whose valve leaks severely and who can't have standard surgery due to other health issues.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
Hear when a new Mitral Regurgitation (MR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.